Caribou Biosciences announced layoffs of 87 employees on October 6, 2026. The CRISPR biotech spun out of Jennifer Doudna's lab halted both of its cancer cell therapy programs after it could not raise funding, and is now weighing a sale or merger. The Berkeley WARN notice covers 87 of its 97 employees.